The Technical Analyst
Nemaura Medical Inc [NMRD]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Nemaura Medical Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-12.78% $0.0567
America/New_York / 25 apr 2024 @ 13:02
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1.638 mill |
| EPS: | -0.390 |
| P/E: | -0.150 |
| Earnings Date: | Jul 12, 2024 |
| SharesOutstanding: | 28.90 mill |
| Avg Daily Volume: | 0.0375 mill |
| RATING 2024-04-25 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | n/a | n/a | n/a | |||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.150 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.150 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0447 - 0.0687 ( +/- 21.17%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-05 | Ghadar-ghadr Arash | Buy | 100 000 | Common Stock |
| 2022-01-05 | Ghadar-ghadr Arash | Buy | 0 | |
| 2022-01-28 | Natha Salim | Buy | 8 000 | Stock Option (right to buy) |
| 2022-01-28 | Moore Thomas Peter | Buy | 8 000 | Stock Option (right to buy) |
| 2022-01-31 | Mclarney Justin James | Buy | 22 293 | Common Stock |
| INSIDER POWER |
|---|
| 100.00 |
| Last 26 transactions |
| Buy: 137 623 617 | Sell: 137 373 875 |
Forecast:
14:42 - $0.0600
Live Trading Signals (every 1 min)
Forecast
1: 13:12 - $0.0600
Forecast 2: 14:02 - $0.0600
Forecast 3: 14:42 - $0.0600
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0567 (-12.78% ) |
| Volume | 0.0826 mill |
| Avg. Vol. | 0.0375 mill |
| % of Avg. Vol | 220.30 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NMRD
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NMRD
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Latest Press Releases
2024-01-03 07:00:00 - Press Release
Important Update On Listing Status And Strategic Direction
Loughborough, uk, jan. 03, 2024 (globe newswire) -- nemaura medical inc. (“nemaura medical” or the “company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will impact nemaura medical's listing status on the nasdaq capital market and our broader strategic direction.
2023-12-13 08:00:00 - Press Release
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
Loughborough, uk, dec. 13, 2023 (globe newswire) -- nemaura medical inc. (nasdaq: nmrd) (“nemaura medical” or the “company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the nasdaq hearings panel granted the company's request for continued listing pursuant to an exception, including certain interim milestones, that ultimately expires on april 1st, 2024, to evidence compliance with all applicable criteria for continued listing on the nasdaq capital market.
2023-11-21 08:30:00 - Press Release
Nemaura Medical Inc. Secures $10 Million Non-dilutive Credit Facility To Fuel Strategic Growth
Loughborough, uk, nov. 21, 2023 (globe newswire) -- nemaura medical inc. (nasdaq: nmrd) (“nemaura medical” or the “company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce the execution of a strategic agreement for a $10 million credit facility which is expected to support the company's strategic growth plans.
2023-11-14 08:00:00 - Press Release
Nemaura Launches Direct To Consumer Offering Of Metabolic Health Program In Combination With Glp-1 Weight Loss Drugs
Company ceo to discuss development at 1pm est on 15 th november 2023, at the sidoti virtual investor conference
2023-11-13 16:14:00 - Press Release
Nemaura Medical Reports Fiscal Second Quarter 2024 Results And Provides Business Update
Loughborough, england, nov. 13, 2023 (globe newswire) -- nemaura medical, inc. (nasdaq: nmrd) (“nemaura” or the “company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today released its financial results for the quarter ended september 30, 2023 and provided a business update.
Latest News
2023-09-18 09:15:00 - GlobeNewsWire
Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference
Loughborough, England, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present business updates and developments at the Maxim Group Emerging Growth in A.I., virtual conference.
2023-09-13 13:05:23 - PennyStocks
Best Penny Stocks To Buy Now? 10 Under $1 To Watch
Let's be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane returns.
2023-08-23 13:32:29 - Zacks Investment Research
Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?
Nemaura Medical, Inc. (NMRD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2023-02-16 08:15:00 - GlobeNewsWire
Nemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference
Loughborough, England, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs, announces that CEO Dr. Faz Chowdhury will participate in a fireside chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference that is being held virtually on February 21 – 24, 2023.
2023-01-11 08:00:00 - GlobeNewsWire
Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference
Loughborough, England, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs, announces that CEO Dr. Faz Chowdhury will present a corporate overview at the Sidoti & Co. Micro Cap Virtual Conference being held on January 18 -19, 2023.
2022-12-01 08:15:00 - GlobeNewsWire
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the Planet MicroCap Showcase: Virtual 2022 being held on December 6 – 8, 2022.
2022-11-11 08:00:00 - GlobeNewsWire
Nemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors Conference
Loughborough, England, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at at the Bernstein 2nd Annual CGM Disruptors Conference which is being held virtually on November 18, 2022.
2022-09-06 08:30:00 - GlobeNewsWire
Nemaura Medical to Present at the 24th Annual H.C. Wainwright Global Investment Conference
Loughborough, England, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the 24th Annual H.C. Wainwright Global Investment Conference, which is being held on September 12 – 14, 2022.
2022-08-15 11:17:40 - Zacks Investment Research
Nemaura Medical, Inc. (NMRD) Reports Q1 Loss, Lags Revenue Estimates
Nemaura Medical, Inc. (NMRD) delivered earnings and revenue surprises of -6.25% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-04-25 08:30:00 - GlobeNewsWire
Nemaura Medical to Present at the Planet MicroCap Showcase 2022
Loughborough, England, April 25, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present virtually at the Planet MicroCap Showcase 2022. The conference is being held on May 3 – 5, 2022 at The Bally's Hotel & Casino in Las Vegas, NV.